Publications
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors2018 | Second Faculty of Medicine
- Trial watch: Peptide-based vaccines in anticancer therapy2018 | Second Faculty of Medicine
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy2016 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer2015 | Second Faculty of Medicine
- Trial Watch: Adoptive cell transfer for oncological indications2015 | Second Faculty of Medicine
- Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Type I interferon and cancer2024 | Second Faculty of Medicine
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...
